Verista’s Post

Update: Thank you, Jason Howard and Tegus team for stepping in promptly and professionally, and launching a full investigation. As partners in the broader compliance ecosystem, we at Gesund.ai value the integrity of our process and experts above all else and appreciate these principles are reflected in Tegus’ actions. ——————— I had the strangest exchange with an investor yesterday who used Tegus' expert elicitation services to conduct a competitive tech assessment on us. This is business as usual for the ecosystem; I, too, routinely get inbound requests from such providers soliciting my input on various technologies for diligence purposes. Tegus interviewed an expert - an executive from a large pharmaceutical company - who talked about their trial with us and compared us against a couple of other companies they used (I wouldn't have picked these two as direct comps but I'll leave that aside for now). Here is the kicker: not only have I never met this pharma executive, we also never worked with this pharma group in any capacity let alone a full-blown trial. Investors: do qualify your sources and references - this could have easily slipped for large companies operating in a large industry.

As dealmaking in biopharma picks up, eClinical CEO Raj Indupuri sees an opportunity for clinical software companies to make acquisitions easier to close. Check out Raj's interview with PharmaVoice's Michael Gibney to learn why data is the most valuable asset, how new technology plays a role in M&A, and ways to address challenges of the current environment: https://lnkd.in/euqUnjHr

Absolutely thrilled to welcome our second acquisition of the year, Insigniam, to the Elixirr family! 💥 Insigniam's clients include one-third of the Fortune 50, over 100 of the Forbes Global 1000, and all 16 of the largest pharmaceutical companies in the world. These clients have documented more than 50x ROI in measurable results; and 85% report that Insigniam provides more value than any other consulting firm! Insigniam's incredible people work at the top of the house to inspire and achieve the cultural change necessary for breakthrough transformation. As a behavioural economist myself, I intuitively leverage heuristics and framing to inspire and accelerate human engagement and adoption. I have no doubt the application of Insigniam's proprietary methodologies will catalyse our clients' results and speed to transformation. 📈 Here's to: - Breakthrough Performance ✅🍾 - Audacious Outcomes ✅🙌 - Being Human ✅🤗 Read more here: https://lnkd.in/eRRBmsdH #acquisition #beinghuman #catalyst #performance #insigniam #msh Nathan Rosenberg Shideh Sedgh Bina Katerin Le Folcalvez Jen Zimmer

We're excited to announce that PSC Biotech has officially joined Kneat's new Partner Program as a Strategic Partner. Through the Kneat and PSC Biotech partnership there is an exciting expansion of services to global Life Science customers. PSC Biotech's broad reach across new regions, combined with their expert validation engineers, will now integrate Kneat's powerful digital validation solution. This partnership is set to provide exceptional value to customers world-wide. With over 26 years in business, PSC Biotech has provided services in CQV, CSV, Quality Assurance, Metrology, and Regulatory Affairs to over a 1000 clients in 52 different countries. PSC Biotech's Kneat portfolio of services will include a managed service offering for customer’s short-term projects or continuous validation needs utilizing Kneat. Looking ahead, PSC Biotech will offer the Kneat Go software & services bundle, alongside their PSC Software Solutions, such as ACE Essential, AuditUtopia, ACE Enterprise, and ACE Inspection. “Kneat is enthusiastic about teaming up with such a prominent global industry leader, as we share common goals of improving efficiency, mitigating risk, and boosting productivity through the adoption of Kneat, the premier digital solution,” says Paul Fahy, Senior Manager of Partner Success at Kneat. “Through our collaboration, PSC Biotech are eager to expand our service offerings to incorporate Kneat for PSC customers. This partnership underscores our commitment to providing comprehensive, innovative solutions that meet the needs of our clients,” says John Clapham, RAC, CEO of PSC Biotech. Interested in joining Kneat’s Partner Program? Get a copy of our guide today: https://hubs.li/Q02ywtVL0 #Kneat #PSCBiotech #PSCSoftware #Partnerships #DigitalValidation

In our industry, there’s one thing you can’t exaggerate about and that’s experience. We are often asked what sets Pharmatech Associates apart. That answer always comes back to experience—the kind that can only be earned over time in the industry trenches. We have over 25 years of leadership in the life sciences industry. We work with clients that range in size from start-ups to large multinationals. Each project is matched with subject matter experts armed with the necessary local regulatory insight to successfully commercialize products in almost any jurisdiction around the world. Yes, experience is everything in our line of work. Let’s talk today. https://hubs.ly/Q02jWLRr0 #PharmaCompliance #pharmaexpertise #pharmaconsulting

KMK disrupts pharma norms by blending secondary data with primary methods for impactful decision-making. Work with a dedicated and versatile team solely dedicated to tackling your unique challenge and gain the advantage of diverse perspectives, deep insights, and expert recommendations. Enjoy the ease of streamlined communication and a seamless onboarding process through a single point of contact. #PharmaInnovation #IntegratedInsights #Primaryresearch

Effective coordination and collaboration among internal and external stakeholders are key to speed study start-up. Learn how a single end-to-end application can help: https://lnkd.in/g-dfnNbV #studystartup #pharma #whitepaper

Thriving across diverse industry verticals, ACCELQ has empowered organizations to attain Continuous Delivery through flawless and dependable test automation. Dive into some of our standout success stories below! 🚀 https://lnkd.in/gWpuKb9Q #ACCELQ #ContinuousDelivery #TestAutomation #SuccessStories"

Navigate the Regulatory Waves with EnkrisiGPT! 🏖️ Imagine yourself standing at the edge of a vast ocean of drug development data, the waves of information lapping at your feet. In the complex world of regulatory compliance, it can feel overwhelming, like trying to map the ever-changing tides. That's where EnkrisiGPT comes in, bringing the refreshing breeze of our Augmented Intelligence Model to your decision-making process. Just as the lighthouse guides the ship, our advanced system processes massive amounts of data efficiently and accurately, illuminating the path to success. With EnkrisiGPT, you gain access to actionable strategies and insights, allowing you to navigate the regulatory seascape with confidence. Whether you're developing small molecules, biologics, or combination products, EnkrisiGPT is your beach umbrella of reliability. You can relax in the knowledge that you're making informed decisions and taking appropriate actions based on analyzed and dependable data. Feel the warmth of certainty and the cool assurance that comes with EnkrisiGPT, the lifeguard of your regulatory journey. 🌴 Dive in today and let the waves of success carry you to new horizons! Contact us for a tailored consultation. 🌴 Madison Peterson Suresh Babu Sally Smith Jyoti Chauhan #regulatoryaffairs #CMC #ai

Episode 4 - PharmaX Offerings Series In continuation to our previous case study episode, please have a look at part two! This episode will elaborate on the #implementation models and #validation models selection, depending on the analysis we did for the customer. Are you liking what you are watching? We'd love to hear your thoughts! Please email us at info@pharmaxsolutions.com if you want to know more about our services or have any questions. Link to the previous episode- https://lnkd.in/dstPFc79 #CaseStudy #CustomerSuccess #Implementation #Validation #PharmaxSolutions #BusinessAnalysis #ClientServices #PharmaX #Consulting ##Talktous #Services #Digitalization #Digitaltransformation #Digitalmanufacturing